Thiem D Phan
Examiner (ID: 7633)
Most Active Art Unit | 3729 |
Art Unit(s) | 3729 |
Total Applications | 2341 |
Issued Applications | 1787 |
Pending Applications | 105 |
Abandoned Applications | 401 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 8270570
[patent_doc_number] => 08212072
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-07-03
[patent_title] => 'Process for the preparation of pregabalin'
[patent_app_type] => utility
[patent_app_number] => 12/983550
[patent_app_country] => US
[patent_app_date] => 2011-01-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3524
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12983550
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/983550 | Process for the preparation of pregabalin | Jan 2, 2011 | Issued |
Array
(
[id] => 8808043
[patent_doc_number] => 08445694
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-05-21
[patent_title] => 'Hydrazonopyrazole derivatives and their use as therapeutics'
[patent_app_type] => utility
[patent_app_number] => 12/977794
[patent_app_country] => US
[patent_app_date] => 2010-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 86998
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12977794
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/977794 | Hydrazonopyrazole derivatives and their use as therapeutics | Dec 22, 2010 | Issued |
Array
(
[id] => 6039418
[patent_doc_number] => 20110092467
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-04-21
[patent_title] => '7-And 9-Carbamate, Urea, Thiourea, Thiocarbamate, And Heteroaryl-Amino Substituted Tetracycline Compounds'
[patent_app_type] => utility
[patent_app_number] => 12/976782
[patent_app_country] => US
[patent_app_date] => 2010-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14790
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0092/20110092467.pdf
[firstpage_image] =>[orig_patent_app_number] => 12976782
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/976782 | 7-And 9-Carbamate, Urea, Thiourea, Thiocarbamate, And Heteroaryl-Amino Substituted Tetracycline Compounds | Dec 21, 2010 | Abandoned |
Array
(
[id] => 8253360
[patent_doc_number] => 20120157688
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-06-21
[patent_title] => 'IMIDAZOLIUM MONOCARBOXYLATE SALT AND METHOD FOR PREPARATION THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/972622
[patent_app_country] => US
[patent_app_date] => 2010-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6277
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0157/20120157688.pdf
[firstpage_image] =>[orig_patent_app_number] => 12972622
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/972622 | IMIDAZOLIUM MONOCARBOXYLATE SALT AND METHOD FOR PREPARATION THEREOF | Dec 19, 2010 | Abandoned |
Array
(
[id] => 9355583
[patent_doc_number] => 08674115
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-03-18
[patent_title] => 'CRTH2 modulators'
[patent_app_type] => utility
[patent_app_number] => 12/969840
[patent_app_country] => US
[patent_app_date] => 2010-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 51755
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12969840
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/969840 | CRTH2 modulators | Dec 15, 2010 | Issued |
Array
(
[id] => 8792766
[patent_doc_number] => 20130109735
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-05-02
[patent_title] => 'SALACINOL AND PONKORANOL HOMOLOGUES, DERIVATIVES THEREOF, AND METHODS OF SYNTHESIZING SAME'
[patent_app_type] => utility
[patent_app_number] => 13/513142
[patent_app_country] => US
[patent_app_date] => 2010-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15022
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13513142
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/513142 | SALACINOL AND PONKORANOL HOMOLOGUES, DERIVATIVES THEREOF, AND METHODS OF SYNTHESIZING SAME | Nov 30, 2010 | Abandoned |
Array
(
[id] => 8858656
[patent_doc_number] => 08461191
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-06-11
[patent_title] => 'Compounds and methods for inhibiting the interaction of BCL proteins with binding partners'
[patent_app_type] => utility
[patent_app_number] => 12/956969
[patent_app_country] => US
[patent_app_date] => 2010-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18425
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12956969
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/956969 | Compounds and methods for inhibiting the interaction of BCL proteins with binding partners | Nov 29, 2010 | Issued |
Array
(
[id] => 6144685
[patent_doc_number] => 20110130387
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-02
[patent_title] => 'SIRTUIN MODULATING COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 12/955663
[patent_app_country] => US
[patent_app_date] => 2010-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 126827
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 27
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0130/20110130387.pdf
[firstpage_image] =>[orig_patent_app_number] => 12955663
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/955663 | Sirtuin modulating compounds | Nov 28, 2010 | Issued |
Array
(
[id] => 12335895
[patent_doc_number] => 09947967
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-04-17
[patent_title] => Fluorosulfonyl imide salt and method for producing fluorosulfonyl imide salt
[patent_app_type] => utility
[patent_app_number] => 13/264244
[patent_app_country] => US
[patent_app_date] => 2010-11-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 10545
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 213
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13264244
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/264244 | Fluorosulfonyl imide salt and method for producing fluorosulfonyl imide salt | Nov 25, 2010 | Issued |
Array
(
[id] => 6186700
[patent_doc_number] => 20110124705
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-05-26
[patent_title] => 'PRODRUGS OF ALPHA-2-DELTA LIGANDS, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/953899
[patent_app_country] => US
[patent_app_date] => 2010-11-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38080
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0124/20110124705.pdf
[firstpage_image] =>[orig_patent_app_number] => 12953899
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/953899 | PRODRUGS OF ALPHA-2-DELTA LIGANDS, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF | Nov 23, 2010 | Abandoned |
Array
(
[id] => 17904287
[patent_doc_number] => 11458119
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-10-04
[patent_title] => Amorphous and a crystalline form of genz 112638 hemitartrate as inhibitor of glucosylceramide synthase
[patent_app_type] => utility
[patent_app_number] => 13/511768
[patent_app_country] => US
[patent_app_date] => 2010-11-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 18182
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13511768
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/511768 | Amorphous and a crystalline form of genz 112638 hemitartrate as inhibitor of glucosylceramide synthase | Nov 23, 2010 | Issued |
Array
(
[id] => 6203140
[patent_doc_number] => 20110065926
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-17
[patent_title] => 'METHOD OF PREPARING IONIC LIQUIDS'
[patent_app_type] => utility
[patent_app_number] => 12/951726
[patent_app_country] => US
[patent_app_date] => 2010-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8804
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0065/20110065926.pdf
[firstpage_image] =>[orig_patent_app_number] => 12951726
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/951726 | METHOD OF PREPARING IONIC LIQUIDS | Nov 21, 2010 | Abandoned |
Array
(
[id] => 6202927
[patent_doc_number] => 20110065713
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-17
[patent_title] => 'Benzazole Derivatives, Compositions, and Methods of Use as B-Secretase Inhibitors'
[patent_app_type] => utility
[patent_app_number] => 12/950718
[patent_app_country] => US
[patent_app_date] => 2010-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 62362
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0065/20110065713.pdf
[firstpage_image] =>[orig_patent_app_number] => 12950718
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/950718 | Benzazole derivatives, compositions, and methods of use as β-secretase inhibitors | Nov 18, 2010 | Issued |
Array
(
[id] => 8199685
[patent_doc_number] => 20120122999
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-05-17
[patent_title] => 'URETHANE AND UREA FLUOROSURFACTANTS'
[patent_app_type] => utility
[patent_app_number] => 12/944802
[patent_app_country] => US
[patent_app_date] => 2010-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6388
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0122/20120122999.pdf
[firstpage_image] =>[orig_patent_app_number] => 12944802
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/944802 | Urethane and urea fluorosurfactants | Nov 11, 2010 | Issued |
Array
(
[id] => 6084026
[patent_doc_number] => 20110144105
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-16
[patent_title] => 'AZAINDOLE GLUCOKINASE ACTIVATORS'
[patent_app_type] => utility
[patent_app_number] => 12/943539
[patent_app_country] => US
[patent_app_date] => 2010-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 112675
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0144/20110144105.pdf
[firstpage_image] =>[orig_patent_app_number] => 12943539
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/943539 | Azaindole glucokinase activators | Nov 9, 2010 | Issued |
Array
(
[id] => 6003352
[patent_doc_number] => 20110118326
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-05-19
[patent_title] => 'Androgen Receptor Modulator and Uses Thereof'
[patent_app_type] => utility
[patent_app_number] => 12/943163
[patent_app_country] => US
[patent_app_date] => 2010-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10144
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0118/20110118326.pdf
[firstpage_image] =>[orig_patent_app_number] => 12943163
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/943163 | Androgen receptor modulator and uses thereof | Nov 9, 2010 | Issued |
Array
(
[id] => 9621099
[patent_doc_number] => 08791273
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-07-29
[patent_title] => '4R,5S-enantiomer of 2-(5-methyl-2-oxo-4-phenyl-pyrrolidin-1-yl)-acetamide with nootropic activity'
[patent_app_type] => utility
[patent_app_number] => 13/508184
[patent_app_country] => US
[patent_app_date] => 2010-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3480
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13508184
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/508184 | 4R,5S-enantiomer of 2-(5-methyl-2-oxo-4-phenyl-pyrrolidin-1-yl)-acetamide with nootropic activity | Nov 3, 2010 | Issued |
Array
(
[id] => 6071539
[patent_doc_number] => 20110046390
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-24
[patent_title] => 'Gas Generant Compositions'
[patent_app_type] => utility
[patent_app_number] => 12/916742
[patent_app_country] => US
[patent_app_date] => 2010-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 2696
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0046/20110046390.pdf
[firstpage_image] =>[orig_patent_app_number] => 12916742
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/916742 | Gas generant compositions | Oct 31, 2010 | Issued |
Array
(
[id] => 8870920
[patent_doc_number] => 08466297
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-06-18
[patent_title] => 'Manufacturing process for (S)-Pregabalin'
[patent_app_type] => utility
[patent_app_number] => 12/925782
[patent_app_country] => US
[patent_app_date] => 2010-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3996
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12925782
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/925782 | Manufacturing process for (S)-Pregabalin | Oct 31, 2010 | Issued |
Array
(
[id] => 5945142
[patent_doc_number] => 20110105762
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-05-05
[patent_title] => 'TOTAL SYNTHESIS OF SALINOSPORAMIDE A AND ANALOGS THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/913624
[patent_app_country] => US
[patent_app_date] => 2010-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 64
[patent_figures_cnt] => 64
[patent_no_of_words] => 30501
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0105/20110105762.pdf
[firstpage_image] =>[orig_patent_app_number] => 12913624
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/913624 | Total synthesis of salinosporamide A and analogs thereof | Oct 26, 2010 | Issued |